Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print RSS Feed

Breaking News

Related Searches: Bio News & Views

December 22, 2009
DSM makes enzyme for Mayoly Spindler at Capua facility.  Read More »

December 18, 2009
Full-year revenues down 9% between commercial and development service groups.  Read More »

December 18, 2009
Astellas pays $40 million for Phase II AML treatment.  Read More »

December 18, 2009
Suzanne Cadden is the new VP of RA & Quality at ImmunoGen.  Read More »

December 17, 2009
GSK pays $10 million alliance after favorable candidate.   Read More »

December 17, 2009
Therapure Biopharma will provide fill and finish services for YM BioSciences' EGFR binder  Read More »

December 17, 2009
Merck buys bio-CMO, will focus on internal pipeline.  Read More »

December 16, 2009
Companies will combine on diabetes drug in Middle Kingdom  Read More »

December 16, 2009
Hospira will acquire the generic injectable finished-dosage form pharmaceuticals business of India-based Orchid for $400 million.  Read More »

December 16, 2009
Covance has opened new clinical development offices in Seoul and Mumbai and has expanded offices in Tokyo and Hong Kong  Read More »

December 15, 2009
Patheon has successfully released the first commercial shipments of Zogenix's Sumavel DosePro  Read More »

December 15, 2009
Darusentan missed its primary endpoints, will likely be canceled.  Read More »

December 15, 2009
Seattle Genetics and Millennium have entered into a development and commercialization agreement for lymphoma treatment brentuximab vedotin.  Read More »

December 15, 2009
Abbott will acquire STARLIMS for $123 million.  Read More »

December 14, 2009
ICON has expanded its European Central Laboratory.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On